Sibopirdine

Sibopirdine

Systematic (IUPAC) name
5,5-bis(4-pyridylmethyl)-5H-cyclopenta[2,1-b:3,4-b']dipyridine
Clinical data
Legal status	Unscheduled
Identifiers
CAS Number	139781-09-2 Y
ATC code	None
PubChem	CID 9929210
ChemSpider	169416 N
UNII	7IKM67CSEQ N
KEGG	D05833 Y
Chemical data
Formula	C23H18N4
Molar mass	350.415 g/mol
SMILES c5cnccc5CC1(Cc3ccncc3)c2cccnc2-c4c1cccn4
InChI InChI=1S/C23H18N4/c1-3-19-21(26-9-1)22-20(4-2-10-27-22)23(19,15-17-5-11-24-12-6-17)16-18-7-13-25-14-8-18/h1-14H,15-16H2 N Key:FJYRSJDIZKTXKB-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Sibopirdine, also known as EXP921, is a nootropic drug.^[1]

Synthesis

Sibopirdine synthesis: DuPont Merck Pharmaceutical Company; U.S. Patent 5,272,269 (1993).

See also

• Besipirdine
• Linopirdine

References

1. ↑ Wong, YN; Quon, CY; Holm, KA; Burcham, DL; Frey, NL; Huang, SM; Lam, GN (February 1996). "Pharmacokinetics and metabolism of EXP921, a novel cognitive enhancer, in rats.". Drug metabolism and disposition: the biological fate of chemicals 24 (2): 172–9. PMID 8742228.